Elizabeth M. Swisher
University of Washington(US)
Publications by Year
Research Areas
PARP inhibition in cancer therapy, Ovarian cancer diagnosis and treatment, BRCA gene mutations in cancer, Cancer Genomics and Diagnostics, DNA Repair Mechanisms
Most-Cited Works
- → Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial(2017)1,678 cited
- → Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial(2016)1,190 cited
- → Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers(2008)1,067 cited
- → Germline and Somatic Mutations in Homologous Recombination Genes Predict Platinum Response and Survival in Ovarian, Fallopian Tube, and Peritoneal Carcinomas(2013)1,038 cited
- → Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing(2011)929 cited
- → Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer(2019)912 cited